Napigen
Latest round
- Seed
Last raised
- Jul 2022
Total raised
- $7.9M
Investors
- 6
About Napigen
Based in Delaware, US, and founded in 2016, Napigen operates as a biotechnology company. The company was founded by its CEO Hajime Sakai, Ganesh Kishore, Roger Wyse, and Jay Keasling. In July 2022, Napigen, Inc. Napigen provides genome technology that focuses on changing cytoplasmic genomes, such as mitochondria and chloroplasts, enabling advancements in agribusiness, industrial biotechnology, and medical research. With the use of the company’s hybridization technology, crop plants that are now primarily non-hybrid, like wheat, can produce non-GM hybrid seeds, enabling a reduction in deforestation, which in turn helps to safeguard our environment and climate.
Who invested in Napigen
6 investors across 2 rounds
See all investors in Napigen
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Napigen
Who invested in Napigen?
Napigen has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Napigen raised?
Napigen has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Napigen last raise money?
Napigen's most recent round on record is a Seed, in Jul 2022.
What does Napigen do?
Based in Delaware, US, and founded in 2016, Napigen operates as a biotechnology company.
Where is Napigen headquartered?
Napigen is headquartered in Wilmington, US.
Which VCs invest in companies like Napigen?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Napigen's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Napigen? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.